Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8QUF

carbonic anhydrase XII mimic in complex with 2-(3-((N-(4-sulfamoylbenzyl)pyridine-3-sulfonamido)methyl)phenoxy)acetic acid

This is a non-PDB format compatible entry.
Summary for 8QUF
Entry DOI10.2210/pdb8quf/pdb
DescriptorCarbonic anhydrase 2, DIMETHYL SULFOXIDE, ZINC ION, ... (5 entities in total)
Functional Keywordscarbonic anhydrase xii mimic, inhibitor, metalloenzyme, sulfonamide, glaucoma, lyase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight30360.47
Authors
Angeli, A.,Ferraroni, M. (deposition date: 2023-10-16, release date: 2024-10-23, Last modification date: 2025-03-26)
Primary citationAngeli, A.,Chelli, I.,Lucarini, L.,Sgambellone, S.,Marri, S.,Villano, S.,Ferraroni, M.,De Luca, V.,Capasso, C.,Carta, F.,Supuran, C.T.
Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy.
J.Med.Chem., 67:3066-3089, 2024
Cited by
PubMed Abstract: Glaucoma, a leading cause of irreversible vision loss worldwide, is characterized by elevated intraocular pressure (IOP), a well-established risk factor across all its forms. We present the design and synthesis of 39 novel carbonic anhydrase inhibitors by a dual-tailed approach, strategically crafted to interact with distinct hydrophobic and hydrophilic pockets of CA active sites. The series was investigated against the CA isoforms implicated in glaucoma (hCA II, hCA IV, and hCA XII), and the X-ray crystal structures of compounds , , and with CA II, along with in complex with a hCA XII mimic, were determined. Selected compounds (, , and ) underwent evaluation for their ability to reduce IOP in rabbits with ocular hypertension. Derivative showed significant potency and sustained IOP-lowering effects, surpassing the efficacy of the drugs dorzolamide and bimatoprost. This positions compound as a promising candidate for the development of a novel anti-glaucoma medication.
PubMed: 38266245
DOI: 10.1021/acs.jmedchem.3c02254
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.141 Å)
Structure validation

236620

PDB entries from 2025-05-28

PDB statisticsPDBj update infoContact PDBjnumon